Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities.

Kim, Tae Kon; Vandsemb, Esten N; Herbst, Roy S; Chen, Lieping

Kim, Tae Kon; Vandsemb, Esten N; Herbst, Roy S; Chen, Lieping.

Afiliación

Kim TK; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Vandsemb EN; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, USA.
Herbst RS; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Chen L; Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, USA.

Nat Rev Drug Discov ; 21(7): 529-540, 2022 07.

Article en En | MEDLINE | ID: mdl-35701637

Asunto(s)

Antígeno B7-H1; Neoplasias; Anticuerpos; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Neoplasias Límite: Humans Idioma: En Revista: Nat Rev Drug Discov Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google